Business Description
Medical Developments International Ltd
ISIN : AU000000MVP2
Total Employee Number:
68Compare
Compare
Traded in other countries / regions
MVP.AustraliaMDDVF.USAM5D.Germany IPO Date
2003-12-15Description
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 12.82 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.51 | |||||
Interest Coverage | 16.26 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.73 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year Book Growth Rate | -18.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.31 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.84 | |||||
9-Day RSI | 56.18 | |||||
14-Day RSI | 55.43 | |||||
3-1 Month Momentum % | 26.32 | |||||
6-1 Month Momentum % | 20 | |||||
12-1 Month Momentum % | -18.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.77 | |||||
Quick Ratio | 4.64 | |||||
Cash Ratio | 3.46 | |||||
Days Inventory | 254.64 | |||||
Days Sales Outstanding | 63.38 | |||||
Days Payable | 160.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | 1.41 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.05 | |||||
Operating Margin % | 2.48 | |||||
Net Margin % | 1.47 | |||||
EBITDA Margin % | 7.64 | |||||
FCF Margin % | 11.64 | |||||
OCF Margin % | 13.51 | |||||
ROE % | 1.13 | |||||
ROA % | 0.97 | |||||
ROIC % | 2.58 | |||||
3-Year ROIIC % | -67.95 | |||||
ROC (Joel Greenblatt) % | 3.12 | |||||
ROCE % | 0.98 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 100 | |||||
Forward PE Ratio | 68.57 | |||||
PE Ratio without NRI | 100 | |||||
Price-to-Owner-Earnings | 83.33 | |||||
PS Ratio | 1.39 | |||||
PB Ratio | 1.01 | |||||
Price-to-Tangible-Book | 1.61 | |||||
Price-to-Free-Cash-Flow | 12.5 | |||||
Price-to-Operating-Cash-Flow | 10.64 | |||||
EV-to-EBIT | 64.37 | |||||
EV-to-Forward-EBIT | 1512.46 | |||||
EV-to-EBITDA | 11.26 | |||||
EV-to-Forward-EBITDA | 98.01 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-Forward-Revenue | 4.68 | |||||
EV-to-FCF | 7.39 | |||||
Price-to-GF-Value | 0.94 | |||||
Price-to-Median-PS-Value | 0.11 | |||||
Price-to-Graham-Number | 2.63 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Price-to-Net-Cash | 4.55 | |||||
Earnings Yield (Greenblatt) % | 1.55 | |||||
FCF Yield % | 8.8 | |||||
Forward Rate of Return (Yacktman) % | -1.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medical Developments International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 42.568 | ||
| EPS (TTM) (A$) | 0.005 | ||
| Beta | 1.7029 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.34 | ||
| Volatility % | 48.5 | ||
| 14-Day RSI | 55.43 | ||
| 14-Day ATR (A$) | 0.027998 | ||
| 20-Day SMA (A$) | 0.48325 | ||
| 12-1 Month Momentum % | -18.64 | ||
| 52-Week Range (A$) | 0.365 - 0.765 | ||
| Shares Outstanding (Mil) | 112.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medical Developments International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medical Developments International Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medical Developments International Ltd Frequently Asked Questions
What is Medical Developments International Ltd(ASX:MVP)'s stock price today?
The current price of ASX:MVP is A$0.50. The 52 week high of ASX:MVP is A$0.77 and 52 week low is A$0.37.
When is next earnings date of Medical Developments International Ltd(ASX:MVP)?
The next earnings date of Medical Developments International Ltd(ASX:MVP) is .
Does Medical Developments International Ltd(ASX:MVP) pay dividends? If so, how much?
Medical Developments International Ltd(ASX:MVP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers